2017 annual financial data
Sarepta Therapeutics 2017 Operating margin
Direct answer
Operating margin was -111.03%.
Operating income was -171,638,000 USD and net income was -50,688,000 USD.
Operating cash flow was -231,996,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 154,584,000 USD
- Operating income
- -171,638,000 USD
- Net income
- -50,688,000 USD
- Operating cash flow
- -231,996,000 USD